Ryan Richardson
Board Member
Autolus Therapeutics plc (AUTL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ryan Richardson
Ryan Richardson is recorded as Board Member at Autolus Therapeutics plc (AUTL). Autolus Therapeutics plc reported in an 8-K filed December 2, 2025 that Ryan Richardson was appointed Class I director, effective December 1, 2025.
“On December 1, 2025, Autolus Therapeutics plc (the "Company") announced that its board of directors (the "Board"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Ryan Richardson to serve as a Class I director of the Company, effective December 1, 2025 and continuing until the Company's 2028 annual general meeting of shareholders, or until his successor has been duly elected and qualified, or until his earlier death, resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-12-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Autolus Therapeutics plc
Other people whose current roles at this company are on record from its filings.
- Michael W. Bonney Chairman, Board Member
- Patrick McIlvenny Chief Accounting Officer
- Rob Dolski Chief Accounting Officer
- Elisabeth ("Lis") Leiderman, M.D. Board Member
- Ravi M. Rao Board Member
- Robert (“Bob”) W. Azelby Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.